Testing (TB)

PPD Skin Testing Valuable in BCG Vaccinated Populations

Published in Medical Letter on the CDC and FDA, November 24th, 1997

Tuberculin skin testing can identify active Mycobacterium tuberculosis infection in children who have received prior bacillus Calmette-Guerin vaccination, according to a report from the U.S. Centers for Disease Control and Prevention (CDC) and the Botswana Ministry of Health.

In a study of tuberculosis infection among children in Botswana, where 90 percent of infants receive bacillus Calmette-Guerin (BCG) vaccination at birth, researcher D. Rumisha and colleagues found that an induration of 10 mm was indicative of active infection and not vaccine-induced anergy.

The authors also found a surprisingly high incidence of tuberculosis infection...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (1997-11-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry